130 related articles for article (PubMed ID: 20482607)
1. Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity.
Ingram G; Bugert JJ; Loveless S; Robertson NP
Eur J Neurol; 2010 Nov; 17(11):1386-9. PubMed ID: 20482607
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
[TBL] [Abstract][Full Text] [Related]
3. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
[TBL] [Abstract][Full Text] [Related]
4. Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
Sisay S; Lopez-Lozano L; Mickunas M; Quiroga-Fernández A; Palace J; Warnes G; Alvarez-Lafuente R; Dua P; Meier UC
J Neuroimmunol; 2017 May; 306():40-45. PubMed ID: 28385186
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
Gieß RM; Pfuhl C; Behrens JR; Rasche L; Freitag E; Khalighy N; Otto C; Wuerfel J; Brandt AU; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
PLoS One; 2017; 12(4):e0175279. PubMed ID: 28388676
[TBL] [Abstract][Full Text] [Related]
6. Anti-EBNA-1 (carboxy-half) IgG antibodies as a seroepidemiological marker for Epstein-Barr virus infection.
Nebel-Schickel H; Hinderer W; Saavedra C; Schmutzler R; Horn J; Vornhagen R; Sonneborn HH
Beitr Infusionsther Transfusionsmed; 1994; 32():134-7. PubMed ID: 9422107
[TBL] [Abstract][Full Text] [Related]
7. EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls.
Mameli G; Cossu D; Cocco E; Masala S; Frau J; Marrosu MG; Sechi LA
J Neuroimmunol; 2013 Nov; 264(1-2):120-2. PubMed ID: 24099984
[TBL] [Abstract][Full Text] [Related]
8. A two-years real-word study with fingolimod: early predictors of efficacy and an association between EBNA-1 IgG titers and multiple sclerosis progression.
Dominguez-Mozo MI; Galán V; Ramió-Torrentà L; Quiroga A; Quintana E; Villar LM; Costa-Frossard L; Fernández-Velasco JI; Villarrubia N; Garcia-Martinez MA; Arroyo R; Alvarez-Lafuente R
Front Immunol; 2024; 15():1384411. PubMed ID: 38911861
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
Kvistad S; Myhr KM; Holmøy T; Bakke S; Beiske AG; Bjerve KS; Hovdal H; Løken-Amsrud KI; Lilleås F; Midgard R; Njølstad G; Pedersen T; Benth JŠ; Wergeland S; Torkildsen O
Mult Scler; 2014 Dec; 20(14):1833-40. PubMed ID: 24842958
[TBL] [Abstract][Full Text] [Related]
10. Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.
Yamazaki M; Kitamura R; Kusano S; Eda H; Sato S; Okawa-Takatsuji M; Aotsuka S; Yanagi K
Clin Exp Immunol; 2005 Mar; 139(3):558-68. PubMed ID: 15730403
[TBL] [Abstract][Full Text] [Related]
11. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
[TBL] [Abstract][Full Text] [Related]
12. Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis.
Zivadinov R; Ramanathan M; Hagemeier J; Bergsland N; Ramasamy DP; Durfee J; Kolb C; Weinstock-Guttman B
Mult Scler Relat Disord; 2019 Nov; 36():101388. PubMed ID: 31525628
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis.
Almohmeed YH; Avenell A; Aucott L; Vickers MA
PLoS One; 2013; 8(4):e61110. PubMed ID: 23585874
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
[TBL] [Abstract][Full Text] [Related]
15. Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.
Csuka D; Simon D; Hóbor R; Uray K; Prohászka Z; Bánlaki Z; Jani PK; Szilágyi Á; Hudecz F; Rajczy K; Beke G; Boros Major A; Tordai A; Illés Z; Berki T; Czirják L; Füst G
Clin Exp Immunol; 2013 Mar; 171(3):255-62. PubMed ID: 23379431
[TBL] [Abstract][Full Text] [Related]
16. The association between anti-EBNA-1 IgG and multiple sclerosis clinical disease activity.
Bahreini SA; Zahednasab H; Saadatnia M; Jabalameli MR
Eur J Neurol; 2010 Oct; 17(10):e95; author reply e96. PubMed ID: 20636367
[No Abstract] [Full Text] [Related]
17. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus and disease activity in multiple sclerosis.
Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
[TBL] [Abstract][Full Text] [Related]
20. Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients.
Villegas E; Santiago O; Carrillo JA; Sorlózano A; Guerrero M; Fernández O; Gutiérrez J
Diagn Microbiol Infect Dis; 2011 May; 70(1):85-90. PubMed ID: 21388770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
